Your browser doesn't support javascript.
loading
Adjuvant Autologous Melanoma Vaccine for Macroscopic Stage III Disease: Survival, Biomarkers, and Improved Response to CTLA-4 Blockade.
Lotem, Michal; Merims, Sharon; Frank, Stephen; Hamburger, Tamar; Nissan, Aviram; Kadouri, Luna; Cohen, Jonathan; Straussman, Ravid; Eisenberg, Galit; Frankenburg, Shoshana; Carmon, Einat; Alaiyan, Bilal; Shneibaum, Shlomo; Ozge Ayyildiz, Zeynep; Isbilen, Murat; Mert Senses, Kerem; Ron, Ilan; Steinberg, Hanna; Smith, Yoav; Shiloni, Eitan; Gure, Ali Osmay; Peretz, Tamar.
Affiliation
  • Lotem M; Sharett Institute of Oncology, Hadassah Hebrew University Hospital, Ein Karem Campus, 91120 Jerusalem, Israel.
  • Merims S; Sharett Institute of Oncology, Hadassah Hebrew University Hospital, Ein Karem Campus, 91120 Jerusalem, Israel.
  • Frank S; Sharett Institute of Oncology, Hadassah Hebrew University Hospital, Ein Karem Campus, 91120 Jerusalem, Israel.
  • Hamburger T; Sharett Institute of Oncology, Hadassah Hebrew University Hospital, Ein Karem Campus, 91120 Jerusalem, Israel.
  • Nissan A; Departments of Surgery, Hadassah Hebrew University Hospital, Mount Scopus Campus, 91240 Jerusalem, Israel.
  • Kadouri L; Sharett Institute of Oncology, Hadassah Hebrew University Hospital, Ein Karem Campus, 91120 Jerusalem, Israel.
  • Cohen J; Sharett Institute of Oncology, Hadassah Hebrew University Hospital, Ein Karem Campus, 91120 Jerusalem, Israel.
  • Straussman R; Department of Molecular Cell Biology, Weizmann Institute of Science, 7610001 Rehovot, Israel.
  • Eisenberg G; Sharett Institute of Oncology, Hadassah Hebrew University Hospital, Ein Karem Campus, 91120 Jerusalem, Israel.
  • Frankenburg S; Sharett Institute of Oncology, Hadassah Hebrew University Hospital, Ein Karem Campus, 91120 Jerusalem, Israel.
  • Carmon E; Departments of Surgery, Hadassah Hebrew University Hospital, Mount Scopus Campus, 91240 Jerusalem, Israel.
  • Alaiyan B; Departments of Surgery, Hadassah Hebrew University Hospital, Mount Scopus Campus, 91240 Jerusalem, Israel.
  • Shneibaum S; Department of Surgery, Tel Aviv Sourasky Medical Center, 64239 Tel Aviv, Israel.
  • Ozge Ayyildiz Z; Department of Molecular Biology and Genetics, Bilkent University, 06800 Ankara, Turkey.
  • Isbilen M; Department of Molecular Biology and Genetics, Bilkent University, 06800 Ankara, Turkey.
  • Mert Senses K; Department of Molecular Biology and Genetics, Bilkent University, 06800 Ankara, Turkey.
  • Ron I; Department of Oncology, Tel Aviv Sourasky Medical Center, 64239 Tel Aviv, Israel.
  • Steinberg H; Sharett Institute of Oncology, Hadassah Hebrew University Hospital, Ein Karem Campus, 91120 Jerusalem, Israel.
  • Smith Y; Genomic Data Analysis Unit, Hebrew University Medical School, 91120 Jerusalem, Israel.
  • Shiloni E; Department of Surgery, Bnai Zion Medical Center, 31048 Haifa, Israel.
  • Gure AO; Department of Molecular Biology and Genetics, Bilkent University, 06800 Ankara, Turkey.
  • Peretz T; Sharett Institute of Oncology, Hadassah Hebrew University Hospital, Ein Karem Campus, 91120 Jerusalem, Israel.
J Immunol Res ; 2016: 8121985, 2016.
Article in En | MEDLINE | ID: mdl-27294163
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cancer Vaccines / Immunotherapy / Melanoma Limits: Aged80 Language: En Journal: J Immunol Res Year: 2016 Document type: Article Affiliation country: Israel Country of publication: Egypt
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Cancer Vaccines / Immunotherapy / Melanoma Limits: Aged80 Language: En Journal: J Immunol Res Year: 2016 Document type: Article Affiliation country: Israel Country of publication: Egypt